Cardiovascular health, part 1: preparticipation cardiovascular screening

about

Prevalence of Cardiovascular Disorders Among Iranian Elite Athletes

P2860

Q37213954-BE58AEE9-6BCD-4DE0-B0AE-2A97DE069E7B

P2860

Cardiovascular health, part 1: preparticipation cardiovascular screening

Item

http://www.wikidata.org/entity/Q36242264

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Cardiovascular health, part 1: preparticipation cardiovascular screening

@ast

Cardiovascular health, part 1: preparticipation cardiovascular screening

@en

type

Item

label

Cardiovascular health, part 1: preparticipation cardiovascular screening

@ast

Cardiovascular health, part 1: preparticipation cardiovascular screening

@en

prefLabel

Cardiovascular health, part 1: preparticipation cardiovascular screening

@ast

Cardiovascular health, part 1: preparticipation cardiovascular screening

@en

P1476

Cardiovascular health, part 1: preparticipation cardiovascular screening

@en

P2093

Sanjaya Gupta

http://www.w3.org/2001/XMLSchema#string

Sharlene M Day

http://www.w3.org/2001/XMLSchema#string

Timir Baman

http://www.w3.org/2001/XMLSchema#string

P2860

Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells

Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression

Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and F

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.

Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes.

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati

P304

500-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1941738109350405

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231215596

http://www.w3.org/2001/XMLSchema#string

P698

23015913

http://www.w3.org/2001/XMLSchema#string

P932

3445149

http://www.w3.org/2001/XMLSchema#string

Cardiovascular health, part 1: preparticipation cardiovascular screening

about

P2860

P2860

Cardiovascular health, part 1: preparticipation cardiovascular screening

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932